Author

Yong Liu

Chinese Academy of SciencesORCID 0000-0002-6173-8186Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Yong Liu4 papers · Beijing University of Posts and Telecommunications

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:imaging· 2 Approach:statistical model· 2 Assay:proteomics· 1

Frequent Co-Authors

Bing LiuiD· 1 shared Haozhang HuangiD· 1 shared Ji-yan CheniD· 1 shared Jing LiuiD· 1 shared Junjie ZhuoiD· 1 shared Ning TaniD· 1 shared Perry Francis Bartlett· 1 shared Shiqun CheniD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Bing LiuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintAug 24, 2025

Mapping renal impairment and cardiac structure and function: a comprehensive analysis of prospective cohort study, Mendelian randomization and shared genetic etiology

Haozhang Huang, Jing Liu, Xiaozhao Lu…·Yong Liu

This study examines the relationship between renal impairment and cardiac structure/function using CMR and genetic methods, finding associations between eGFR reduction and cardiac parameters.

DOI 10.1101/2025.08.24.25333620

𝕏 PostBluesky

NeurosciencebioRxivPreprintMay 8, 2020

Clinical and biomarker changes in sporadic Alzheimer's disease

Junjie Zhuo, Yuanchao Zhang, Bing Liu…·the Alzheimer’s Disease Neuroimaging Initiative

This study examines how amyloid-beta biomarkers and clinical profiles change in sporadic Alzheimer's disease, finding that amyloid changes are inconsistent with clinical and imaging markers during progression.

DOI 10.1101/2020.05.08.084293

𝕏 PostBluesky